Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction

BACKGROUND: The liver effect of orlistat as a weight control treatment in patients with nonalcoholic fatty liver disease (NAFLD) with obesity remains undetermined. This study quantified liver fat improvement by orlistat in a Chinese cohort with NAFLD accompanied by obesity, diagnosed by a lower body...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Therap Adv Gastroenterol
Main Authors: Ye, Junzhao, Wu, Yanqin, Li, Fuxi, Wu, Tingfeng, Shao, Congxiang, Lin, Yansong, Wang, Wei, Feng, Shiting, Zhong, Bihui
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2019
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6767749/
https://ncbi.nlm.nih.gov/pubmed/31632457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284819879047
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki